Q1-FY24 · Ramandeep Singh Sahni
We have said that there will be some stress on the bottom line as we start expanding. I think some of the expansion which we've done in the last 12 months has started to show the results.
BAJAJFINSV / language trends
Read confidence between the lines.
Bajajfinsv · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q1-FY24 · S. Sreenivasan
The company's goal is to grow its NBV. End of the day, we should grow our margins at least at the same rate as IRNB or better if we can.
Q1-FY24 · S. Sreenivasan
We have transformed the company from where it was, from a negative margin to a fairly healthy double-digit margin. We have some way to go, and over the next few years, you will see this playing a lot more effectively.
Q1-FY25 · S. Sreenivasan
We do not believe such claims are recurring in nature, but it so happened in the Q1 of the year, but hopefully they will not recur in the next remaining three quarters.
Q1-FY25 · S. Sreenivasan
Our margins have been consistently expanding over the last 4-5 years, from 7% in FY 2019 to 15% in FY 2024. The changes in regulations in the short term may temporarily impact the margin expansion.
Q1-FY25 · Devang Mody
If you are able to add value, people will work with you. That is our experience from last four, five quarters.
Q1-FY26 · Tapan Singhel
The endeavor for our company is to always maintain a combined ratio close to 100, is what I've always mentioned over time.
Q1-FY26 · Tarun Chugh
The H2 growth, yes, will be significantly comfortable, is what I can say.
Q1-FY26 · Tapan Singhel
We are not somebody who, in desperation, would do business just for the sake of pushing up a top line.
Q2-FY24 · Tapan Singhel
We have never done business in a desperate manner. We have always done business the way business should be done.
Q2-FY24 · Devang Mody
Our purpose is to create platform to carry out health transactions for customers. It's not about acquiring customers, it's all about enabling transactions digitally.
Q2-FY24 · S. Sreenivasan
In insurance, you always do business on expectation of profit. If I definitely know that I'm going to lose money, I'll never do that business.
Q2-FY25 · S. Sreenivasan
We have built two solid businesses in life and general insurance business, and we have always held some focus on equity stake, and this will continue to be, Bajaj will continue to be the dominant shareholder in this business, in the times to come.
Q2-FY25 · Tapan Singhel
If you look at our combined ratio, which has always been among the best in the industry.
Q2-FY25 · Tarun Chugh
We are now the third largest company in the life sector in terms of the number of policies we sell in the private sector.
Q2-FY26 · Ramandeep Sahni
We have cut about 25% of its unsecured MSME volumes, and thus the AUM growth for MSME lending will be close to about only 10%-12% for the full year, 2026.
Q2-FY26 · Ramandeep Sahni
The VNB for Q2 is reported at INR 367 crore, as against INR 245 crore for the same period last year, a significant 50% increase versus last year.
Q2-FY26 · Ramandeep Sahni
We are now preparing to conclude the acquisition of Allianz's stake in our insurance companies in the next few months.
Q3-FY24 · Tapan Singhel
We are obsessed about customers, innovate, bring in new innovation to the market, look at all segments of businesses, and ensure that we have healthy growth, and we also take care of our bottom line and solvency.
Q3-FY24 · Tarun Chugh
We intend to not being lopsided in any one relationship. I think that's been a strategic decision that we have taken, which is why we actively go ahead and sort out new bank partners, and our agency channels and our direct channels have been fast growing.
Q3-FY24 · Devang Mody
With acquisition of Vidal, we get access to healthcare spends in hospitalization. As I told, it is the largest spend pool in healthcare ecosystem at this point of time in India.
Q3-FY25 · S. Sreenivasan
We believe in the long run, the life business is all about balance. Balance across distribution between channels, balance across products in terms of risk between par, non-par savings, term, and ULIP, and balance between profitability and growth.
Q3-FY25 · Tapan Singhel
A good company is like a good orchestra. The right kind of instruments should be playing at the right time for good music to come.
Q3-FY25 · Tarun Chugh
We've gone ahead and changed practically all our products, including ULIP, PAR, and non-PAR. ... This is a significant overhaul.
Q3-FY26 · Ramandeep Singh Sahni
We are possibly among the top five to six companies, the only one which is truly diversified.
Q3-FY26 · Ramandeep Singh Sahni
The combined ratio for Bajaj General will be among the lowest in the multiline market, with the ROE reasonably above 22%, excluding the surplus capital at 200% solvency.
Q3-FY26 · Ramandeep Singh Sahni
We may not necessarily focus just on growth on agency. This is just the strategy is getting cooked as we go.
Q4-FY24 · S. Sreenivasan
Bajaj continues to balance growth with profitability and consistently delivers a superior combined ratio versus the industry.
Q4-FY24 · Tapan Singhel
We are never into this rush of acquiring business just for the sake of acquiring business. It has to be done sensibly, because in generation business, it's a very long-term business.
Q4-FY24 · Tarun Chugh
The company has had a turnaround in the last 5-6 years. And we've moved into positive territory on margin about 5-6 years back, and the direction is only up.
Q4-FY25 · S Sreenivasan
We are using this opportunity on Team AI and BFL in looking at our OpEx cost in Band-Aid and the margin profiles, restructuring the business on different charges.
Q4-FY25 · Tarun Chugh
We have also taken significant calls on cost structures, looking at more productive investments, removing wastage, inefficiency, and some places significant cost cuts. This is helping us leverage to an extent you saw that operating leverage show up in Q4.
Q4-FY25 · Tapan Singhel
If the CBR rule changes, if the fact gets more difficult, we have enough to be able to retain also, and we have enough underwriting competence, which you demonstrated for several years, to write good risk.
Q4-FY26 · Ramandeep Singh Sahni
Made in India, made for India, and made by India.
Q4-FY26 · Tarun Chugh
Directionally, we can tell you we are in a positive trajectory and all those changes are resulting in the positive margin, we're not gonna indicate any margin.
Q4-FY26 · Tapan Singhel
We are a company which is there for 100 years. It is not a company which we are looking at a short term... It will always do prudent underwriting.